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Genomic imprinting leads to preferred expression of
either the maternal or paternal alleles of a subset of
genes. Imprinting isessential formammaliandevelop-
ment, and its deregulation causes many diseases.
However, the functional relevance of imprinting at
the cellular level is poorly understood for most im-
printed genes. We used mosaic analysis with double
markers (MADM) in mice to create uniparental
disomies (UPDs) and to visualize imprinting effects
with single-cell resolution. Although chromosome
12UPDdidnotproducedetectablephenotypes, chro-
mosome 7 UPD caused highly significant paternal
growth dominance in the liver and lung, but not in
thebrainorheart.Asinglegeneonchromosome7,en-
coding the secreted insulin-likegrowth factor 2 (IGF2),
accounts for most of the paternal dominance effect.
Mosaic analyses implied additional imprinted loci on
chromosome 7 acting cell autonomously to transmit
the IGF2 signal. Our study reveals chromosome- and
cell-type specificity of genomic imprinting effects.
INTRODUCTION
In diploid organisms, most genes are expressed from both
parental chromosomes. However, a subset of genes in
mammals and plants is subject to a unique mode of regulation
called genomic imprinting (Barlow, 2011; Bartolomei and Fergu-
son-Smith, 2011), whereby either the maternal or paternal allele
is preferentially silenced. Genomic imprinting is essential for
embryonic development in mammals (Barton et al., 1984;
McGrath and Solter, 1984; Surani et al., 1984). Deregulation of
imprinting has been implicated in many diseases, including
cancer and brain disorders such as Angelman and Prader-Willi
syndromes (Feinberg, 2007; Mabb et al., 2011; Nicholls and
Knepper, 2001). Despite the importance of imprinting in control-
ling prenatal growth, behavior, and metabolism of the whole
organism (Ferguson-Smith, 2011; Wilkinson et al., 2007), the
functional relevance of imprinting at the cellular level is poorly
understood for most genes.
The analysis of mice carrying uniparental disomy (UPD) of
whole chromosomes (somatic cells with two copies of either960 Cell Reports 3, 960–967, March 28, 2013 ª2013 The Authorsthe maternal or paternal chromosome), as well as duplication
and deficiency of defined chromosomal regions, has been
fundamental for the identification and mapping of imprinted
chromosomal regions and loci in the mouse genome (Cattanach
and Kirk, 1985; Williamson et al., 2013). However, phenotypic
analysis of mice with UPD, deletions, and duplications is limited
due to the lack of assays with cellular resolution. Only very
recently, the analysis of paternally or maternally inherited muta-
tions with concurrent cell marker labeling has begun to reveal
tissue-specific physiological functions for certain imprinted
genes (Ferro´n et al., 2011; Garfield et al., 2011). Here, we use
the mosaic analysis with double markers (MADM) system
(Zong et al., 2005) to probe the effects of genomic imprinting
at the whole-chromosome level and with single-cell resolution
across many tissues and cell types in the mouse.
RESULTS AND DISCUSSION
MADM Can Assess Genomic Imprinting Phenotypes
with Single-Cell Resolution
MADMcangenerateCre/LoxP-dependentmitotic recombination
between homologous chromosomes and at the same time label
genetically defined progeny with distinct fluorescent markers.
Specifically, mitotic recombination at G2 phase followed by X
segregation of recombined chromosomes can produce fluores-
cently labeled progeny with chromosomal compositions distinct
fromparental cells (Zonget al., 2005). Even for chromosomes that
do not harbor any mutations, G2-X events produce near-
complete UPD for a particular chromosome carrying the MADM
cassettes (Figures 1A and S1A). Consequently, imprinted genes
located on such a chromosome will be homozygosed and either
overexpressed by a factor of two or not expressed depending on
their imprinting status. Furthermore, cellswith unipaternal disomy
are fluorescently labeled with GFP and sister cells with unimater-
nal disomy with tandem dimer Tomato (tdTomato), or vice versa
(Figures 1A and S1A). Thus,MADMprovides in principle a unique
experimental platform to systematically assay the consequences
of genomic imprinting at the whole-chromosome level by visual-
izing the single-cell phenotypes of defined UPDs in genetic
mosaic animals.
Chromosome 7, but Not Chromosome 12, UPD Leads
to Drastic Paternal Growth Dominance in the Liver
To test thepotential effect of imprintedgenesonspecificchromo-
somes,weproducedMADMcassettes formouse chromosome7
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Figure 1. MADM Reveals a Chromosome-Specific Imprinting Phenotype with Single-Cell Resolution
(A) G2-X MADM events result in near-complete uniparental chromosomal disomy labeled in green (PP) and red (MM) fluorescent colors, respectively.
(B) Chromosomal location of Hipp7 (chromosome 7) and John12 (chromosome 12) genomic loci with inserted MADM cassettes.
(C and D) P21 livers from MADM-7GT/TG;Hprt-Cre+/ mice with uniparental chromosome 7 disomy.
(E and F) P21 livers from MADM-12GT/TG;Hprt-Cre+/ mice with uniparental chromosome 12 disomy.
(G) Quantification of the PP/MM ratios of liver UPD hepatocytes in cryosections in P21MADM-7GT/TG;HprtCre/+ (MADM-7) andMADM-12GT/TG;HprtCre/+ (MADM-
12; n = 16 from 3 individual malemice). Values represent mean ±SEM. For detailedmethods of quantifying the PP/MM ratio inMADM-7 P21 liver, see also Figures
4 and S4.
Depending on whether theGT and TG alleles were introduced from the father (blue) or the mother (pink), unipaternal disomy cells are labeled in green (C and E) or
in red (D and F) as indicated. Scale bar, 200 mm. See also Figure S1.because mouse chromosome 7 is most enriched for imprinted
genes and harbors several well-studied clusters of imprinted
genes (Williamson et al., 2013). We inserted MADM cassettes
near the centromere of chromosome 7 (Figures 1B and S1B;
see Experimental Procedures for details) using a similar knockin
strategy as previously described (Hippenmeyer et al., 2010). We
then used a ubiquitous Cre driver (Hprt-Cre) to induce chromo-
some 7 UPD across the whole animal in a mosaic fashion.
When using GFP to label unipaternal disomy cells (PP), we found
amassive expansion of green hepatocytes in the liver (Figures 1C
and 1G) when compared with unimaternal disomy cells (MM)
labeled by tdTomato. In a separate experiment in which we
switched colors of UPD cells (tdTomato for PP, and GFP for
MM),we found that redhepatocytesexpandedasaconsequence
of the chromosome 7 UPD (Figure 1D). Thus, unipaternal disomy
of chromosome 7 leads to a massive expansion of hepatocytes
when compared with unimaternal chromosome 7 disomy.
We also created MADM cassettes near the centromere of
mouse chromosome 12 for mosaic analysis of candidate geneson that chromosome (Figures 1B and S1C). Hprt-Cre together
with the MADM transgenes on chromosome 12 also produced
chromosome 12 UPD cells in a mosaic fashion across the whole
animal and including the liver. In contrast to chromosome 7UPD,
hepatocytes carrying either paternal or maternal chromosome
12 UPD appeared similar in number (Figures 1E–1G).
Imprinting Effects in Chromosome 7 UPD Display
Cell-Type Specificity
We extended our analysis to additional tissues and cell types
with mosaic chromosome 7 or chromosome 12 UPD. Qualitative
(Figures 2A–2C and 2E–2G) and quantitative (Figure 2I) evalua-
tion of hippocampal CA1 pyramidal neurons and cerebellar Pur-
kinje cells in the brain, as well as cardiomyocytes in the heart, re-
vealed no significant differences in cell number regardless of
whether these cells carried unipaternal or unimaternal disomies
for chromosome 7 or chromosome 12. By contrast, lung epithelia
displayed a marked expansion of cells with unipaternal chromo-
some 7 but not chromosome 12UPD (Figures 2D and 2H), similarCell Reports 3, 960–967, March 28, 2013 ª2013 The Authors 961
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Figure 2. Cell-type-Specific Paternal Domi-
nance of Chromosome 7 UPD
(A–H) MADM labeling of chromosome 7 (A–D) and
chromosome 12 (E–H) in the hippocampus (A and
E), cerebellum (B and F), heart (C and G), and lung
(D and H) at P21. PP cells are green, and MM cells
are red. DAPI stainings (blue) outline the general
organization of the hippocampus (A and E) and
cerebellum (B and F). Scale bar, 200 mm.
(I) Quantification of the ratios of green PP to red
MM cells in cryosections: cardiomyocytes in the
heart ([n = 16 for M7; n = 10 for M12] from male
animals [n = 3 each]), CA1 pyramidal neurons in
hippocampus ([n = 16 for M7; n = 11 for M12] from
individual male animals [n = 3 each]), and Purkinje
cells (PC) in cerebellum from entire male half-
brains (n = 4 for M7 and n = 3 for M12). Individual
data points as well as mean ± SEM are indicated.
See also Figure S2.to liver hepatocytes. We conclude that MADM-induced chromo-
some 7 but not chromosome 12 UPD results in cell-type-specific
expansion with unipaternal disomy.
To exclude the possibility that the MADMmarkers on chromo-
some 7 themselves were selectively silenced due to imprinting,
we generated mice containing constitutively expressed, recon-
stituted GFP (Hipp7GG/+) and tdTomato (Hipp7TT/+) markers,
respectively, and intercrossed them to generate Hipp7GG/TT
animals. All cells in every organ analyzed at postnatal day (P)
21 in Hipp7GG/TT expressed both markers uniformly (Figure S2).
Therefore, the unequal ratio of hepatocytes and lung epithelia
with unipaternal over unimaternal chromosome 7 UPD did not
result from selective silencing of one marker in putative GFP+/
tdTomato+ cells but reflects an imprinting phenotype whereby
cells with unipaternal disomy have a growth advantage over un-
imaternal disomy.
Paternal Growth Advantage in Chromosome 7 UPD
Commences during Embryogenesis
What is the developmental origin of cell number expansion in uni-
paternal chromosome 7 disomy? To address this question, we
carried out a developmental time course analysis focusing on
liver hepatocytes with MADM-induced chromosome 7 UPD. At
embryonic day (E) 12, no expansion of the hepatocyte population
with unipaternal disomy was apparent (Figure 3A). However,
4 days later at E16, unipaternal chromosome 7 disomy cells
already outnumbered unimaternal chromosome 7 disomy cells
(Figure 3B). We validated this result by clonal analysis using
tamoxifen (TM)-induced CreER (Figures 3J and 3K). In liver962 Cell Reports 3, 960–967, March 28, 2013 ª2013 The Authorsclones induced at E12, the size of clone-
harboring PP cells already exceeded
that of MM by more than 2-fold by E16.
These findings are consistent with
previous reports showing that the embry-
onic liver has a remarkable capacity for
growth (Stanger et al., 2007).
Expansion of the MADM-labeled
domains with unipaternal chromosome7 hepatocytes became more apparent at postnatal stages
(Figures 3C–3F). Nevertheless, mosaic MADM-7 livers were
neither larger than wild-type nor displayed any signs of tumors
in mice of up to 6 months of age, suggesting that cell expansion
due to unipaternal disomy still follows organ size control mech-
anism as in wild-type hepatocytes (Stanger, 2008). In contrast
to hepatocytes with unipaternal chromosome 7 disomy, hepato-
cytes with either UPD for chromosome 12 displayed equal
numbers postnatally up to 6 months (Figures 3G–3I).
Ablation of a Single Gene on Chromosome 7, Igf2,
Largely Mitigates Paternal Growth Advantage
of Chromosome 7 UPD
The paternal dominance of chromosome 7 disomy cells could, in
principle, reflect the consequence of homozygosingmany or just
a few imprinted genes on chromosome 7. Because the ‘‘imprin-
tome’’ of chromosome 7 in the liver is currently unknown, we
pursued a candidate gene approach to identify the causal
gene. Chromosome 7 harbors several clusters of imprinted
genes that either promote or antagonize growth, including pater-
nally expressed Igf2 (insulin-like growth factor 2) (DeChiara et al.,
1991), as well as maternally expressed H19 (Bartolomei et al.,
1991) and Cdkn1c (cyclin-dependent kinase inhibitor 1C, aka
p57kip2) (Hatada and Mukai, 1995; Matsuoka et al., 1995). The
growth advantage of unipaternal disomy can be caused by over-
expression of paternally expressed growth-promoting gene(s),
absence of maternally expressed growth-antagonizing gene(s),
or a combination of both. We began by assessing the involve-
ment of Igf2 and introduced a null allele from the father into our
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Figure 3. Paternal Dominance of Chromosome 7 UPD Initiates
during Embryogenesis
(A–I) Time course analysis of liver at times indicated in MADM-7GT/TG;Hprt-
Cre+/ (A–F) and MADM-12GT/TG;Hprt-Cre+/ (G–I).
(J and K) Clonal analysis in MADM-7GT/TG;bactin-CreER+/ liver. (J) A repre-
sentative image of a single G2-X MADM clone at E16 with TM injected at E12.
Note the increased expansion of green PP when compared to red MM chro-
mosome 7 cells. (K) Quantification of G2-X MADM clones. The mean ± SEM of
the PP/MM ratio is 2.3 ± 0.3 (n = 15).
In all panels, PP cells are green, and MM cells are red. Scale bars, 180 mm (A),
200 mm (B), 250 mm (C), 300 mm (D–I), and 50 mm (J).MADM analysis. Because Igf2 is paternally expressed in most
cells (DeChiara et al., 1991), Igf2m/ (m stands for the wild-type
allele inherited from the mother) should in principle be equivalent
to homozygous Igf2/. Remarkably, we found a striking reduc-
tion of the large clusters of unipaternal chromosome 7 disomy
cells at P21 in Igf2m/-MADM (Figures 4A and 4D compared
with Figures 4B and 4E; Figures S3A and S3B).
To compare hepatocyte expansion with unipaternal chromo-
some 7 disomy produced by MADM in control mice and mice
with paternal loss of Igf2, we quantified all green and red cells
in entire liver sections to avoid selection bias and calculated their
ratios (Figures 4G, S4A, and S4B). We found an 8.6- ± 0.9-foldpaternal expansion in control-MADM. The PP/MM ratio was
reduced to 2.2- ± 0.4-fold in animals with Igf2m/-MADM. To
test whether the residual paternal dominance was due to IGF2
from a possible reactivation of the silenced maternal Igf2 allele,
or in serum fromdistinct sources not subjected to imprinting (De-
Chiara et al., 1991), we also examined the liver from homozygous
Igf2/ mutants with MADM labeling (Figures 4C and S3C). We
found a reduction of the PP/MM ratio (Figure 4F) to the same
level (2.1 ± 0.5) as when the Igf2 mutation was introduced only
from the father. By contrast, maternal transmission of the Igf2
mutation had no effect on paternal dominance (Figures S3D,
S4C, and S4D). Thus, the loss of the paternally inherited Igf2 fully
accounts for the imprinting effect.
To extend our findings to other tissues, we also examined the
effect of IGF2 on the paternal growth dominance in the lung
epithelia. We found that paternal transmission of the Igf2 muta-
tion also resulted in marked reduction of paternal growth domi-
nance in the lung (Figures S4E–S4H), highlighting a general
role of Igf2 imprinting in distinct cell types. Taken together, these
findings indicate that Igf2 is a major factor driving unipaternal
chromosome 7 growth dominance in the liver and lung.
Evidence that Additional Imprinted Factors on
Chromosome 7 Act Cell Autonomously to Receive
the IGF2 Signal
Although chromosome 7 harbors many imprinted genes control-
ling growth, we found that mutation of just one paternally ex-
pressed gene, Igf2, mitigates the majority of the paternal domi-
nance effect. Our findings are in line with previous chimera
studies implicating that duplication of distal chromosome 7
(where Igf2 is located) and Igf2 itself are responsible for causing
overgrowth (Ferguson-Smith et al., 1991; McLaughlin et al.,
1997). We further extended these studies with single-cell resolu-
tion by producing and visualizing UPD through rare mitotic
recombination events enabled by MADM.
However, it is surprising that a secreted factor should be
a major contributor in our experimental setting. Under the
control-MADM-7 condition, all unipaternal disomy cells that
overexpress Igf2 originate from mitotic recombination events in
a single cell and are surrounded by a vast majority of cells with
regular paternal Igf2 expression. Even with paternal growth
dominance, unipaternal cells represent only a small fraction of
the whole liver (see Figure S4A). We envision three possibilities
to explain the paternal growth dominance that we observed in
MADM-7mice (Figure 4H). First, despite being a secreted factor,
IGF2 acts predominantly cell autonomously. Furthermore, a
2-fold increase in IGF2 levels should greatly facilitate the growth
of the unipaternal cells. We consider the first possibility unlikely
because IGF2 is well known to bind IGF-binding proteins,
enabling IGF2 distribution in the bloodstream and thus to signal
growth of neighboring cells in paracrine and endocrine manners
(Chao and D’Amore, 2008). Second, in addition to IGF2, another
paternally expressed P factor acts cell autonomously to posi-
tively regulate IGF2 signal transmission. Again, this P factor
should act in a dose-dependent fashion to account for the
growth of unipaternal chromosome 7 disomy cells in a mostly
wild-type background because it would also be present in
2-fold higher dosage levels, similar to IGF2. Third, a maternallyCell Reports 3, 960–967, March 28, 2013 ª2013 The Authors 963
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Figure 4. Igf2 Accounts for Most of the Paternal Dominance in Chromosome 7 UPD
(A–C) Schematic of Igf2 expression in MADM-7GT/TG;Hprt-Cre+/. (A) Control-MADM-7. (B) Igf2 mutation on paternal chromosome. (C) Igf2 mutation on both
paternal and maternal chromosomes. Note that due to Igf2 imprinting, most cells in (B) do not express Igf2.
(D–F) Labeling of uniparental chromosome 7 disomy (PP cells are green, andMMcells are red) in P21 control, paternal Igf2mutant, or homozygous Igf2/mutant
MADM animals corresponding to the schemes in (A–C). Scale bar, 110 mm.
(G) Quantification of PP/MM ratio in whole-liver sections from P21 MADM animals with genotypes indicated. Values represent mean ± SEM. *p < 0.05 and
**p < 0.01.
(H) Three possible models to account for expansion of cells with unipaternal disomy in sparsely generated MADM-7 clones in wild-type animal. Assuming the
crossing scheme in Figure 1A, cells with unipaternal chromosome 7 disomy (pUPD7) are labeled in green and cells with unimaternal chromosome 7 disomy
(mUPD7) in red upon a G2-X MADM event. Green pUPD7 cells express a double dose of Igf2 and P factor(s) but lack M factor(s), where P or M factors represent
additional imprinted genes on chromosome 7 that could act cell autonomously to promote or inhibit IGF2 signaling, respectively. In Model 1, IGF2 (double dose)
signals strictly autocrine to only pUPD7, but not to mUPD7. In Model 2, the double dose of additional imprinted P factor(s) acts in concert with secreted IGF2 to
convey the growth advantage in pUPD7. In Model 3, the lack of M factor(s), which normally would tune down the IGF2 signal to a certain extent, promotes
increased IGF2 growth signaling in pUPD7 cells. The cell-type specificity of UPD7 effects we observedmay be a consequence of cell-type-specific expression of
the M or P factors, or cell-type-specific interactions of these factors with IGF2.
See also Figures S3 and S4.
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expressed M factor acts cell autonomously to negatively regu-
late IGF2 signal transmission. In unipaternal chromosome 7 dis-
omy cells, the lack of the negative M factor results in greatly
amplified IGF2 growth signaling.
In both the second and third possibilities above, the additional
chromosome 7 P or M imprinted factors contribute, at most, a
2-fold difference independent of IGF2, and their major actions
are manifested in the context of cell-autonomous IGF2 signal
transmission. We favor the third model because it requires the
least number of assumptions; indeed, Cdkn1c could represent
an attractive candidate for the M factor because genetic interac-
tions have been demonstrated between Igf2 and Cdkn1c (Casp-
ary et al., 1999).
Although Igf2 displays a highly specific expression pattern in
the brain, it is broadly expressed in peripheral embryonic tissues
such as the liver, lung, and heart (Davies et al., 2002; DeChiara
et al., 1991; Lehtinen et al., 2011). Because we have only de-
tected a significant proliferation advantage in the liver and
lung, but not in the heart or the brain, it is highly unlikely that
the cell-type-specific effect of imprinting is accounted for by
tissue-specific Igf2 expression patterns. Rather, the tissue spec-
ificity of the imprinting effect is likely caused by tissue-specific
expression of the M or P factors, or their tissue-specific interac-
tions with IGF2.
Conclusions
We have used the MADM strategy to create, and concomitantly
visualize with distinct fluorescent colors, cells with unipaternal
and unimaternal near whole-chromosomal disomy. Conse-
quently, it is possible to assay the phenotype of genomic
imprinting at the single-cell resolution in virtually any tissue or
organ and potentially for every chromosome in the mouse. The
results from MADM of chromosome 7 and chromosome 12 re-
vealed chromosomal as well as cell-type-specific imprinting
phenotypes. The cell-type specificity of genomic imprinting indi-
cates that certain genes exploit parentally controlled expression
regulation in order to fulfill their appropriate physiological
functions.
A salient advantage of the MADM method is the controlled
generation of defined unipaternal and unimaternal disomic cells
that are labeled by two distinct fluorescent colors at the single-
cell resolution. This provides a sensitive means to detect
phenotypes for homozygosing imprinted genes controlling cell
proliferation (such as Igf2 presented in our study), size, and
morphogenesis. An important feature is that MADM-induced
UPD cells always display the combined phenotype of the entire
cohort of imprinted genes located on a particular chromosome.
This could be a limitation when it comes to identifying specific
genes on the chromosome that contribute to the imprinting
phenotypes. Therefore, the MADM approach complements
rather than replaces conventional and/or conditional knockout
experiments to study the function of imprinted genes. We pre-
sented an example of combining MADM to analyze whole-chro-
mosome UPD with mutation in a selected candidate gene, Igf2,
and deduced the quantitative contribution of Igf2 to the
imprinting effect of the entire chromosome.
Finally, MADM analysis has been critical to study cell-autono-
mous functions of candidate genes (besides Igf2 described inthis study) in cell proliferation, neuronal migration, dendrite
morphogenesis, and tumor growth (Espinosa et al., 2009; Hip-
penmeyer et al., 2010; Liu et al., 2011; Muzumdar et al., 2007).
The establishment of MADM cassettes on chromosome 7 and
chromosome 12 now allows mosaic analysis of a vast majority
of genes (2,500 on chromosome 7, and 950 on chromosome
12) on two new chromosomes in addition to our previous efforts
(Hippenmeyer et al., 2010; Tasic et al., 2012; Zong et al., 2005).
Together, MADM-7 and MADM-12 almost double the total
number of mouse genes that can be subjected to MADM
analysis.
EXPERIMENTAL PROCEDURES
Generation of MADM-7 and MADM-12 Mice and Mouse Genetic
Techniques
MADM-7 and MADM-12 mice were generated following a previously
described strategy (Hippenmeyer et al., 2010). In brief, for MADM-7 and
MADM-12-targeting constructs, we identified suitable genomic loci on chro-
mosome 7 (Hipp7 located at 2.13cM; 0.7 kb downstream of exon 5 of the
Rps9 gene) and chromosome 12 (John12 located at 1.71cM; 16 kb down-
stream of exon 1 of the Rab10 gene). The Hipp7 and John12 genomic loci
were cloned, GT and TG MADM cassettes (Hippenmeyer et al., 2010; Liu
et al., 2011) inserted, and targeting vectors constructed using standardmolec-
ular biology procedures (details are available upon request). Linearized target-
ing vectors were then electroporated into R1 ES cells, and two correctly
targeted GT and TG clones for each MADM-7 and MADM-12, respectively,
were injected into blastocysts to generate chimeric mice. Homozygous
MADM-7GT/GT, MADM-7TG/TG, MADM-12GT/GT, MADM-12TG/TG, and transhe-
terozygous MADM-7GT/TG and MADM-12GT/TG were born at Mendelian
frequencies, had a normal lifespan, were fertile, showed no obvious averse
phenotype, and did not exhibit GFP/tdTomato marker expression in the
absence of Cre recombinase.
Heterozygote Igf2+/ (DeChiara et al., 1990), bactin-CreER+/ (Guo et al.,
2002), and hemizygote HprtCre/Y (Tang et al., 2002) mice have been described.
Timed pregnancies were set up to generate embryos at defined develop-
mental stages. For the generation of recombinant MADM-7GT,Igf2/TG or
MADM-7GT/TG,Igf2, we followed a standard breeding strategy as previously
described (Hippenmeyer et al., 2010). The MADM experiments described in
this study were carried out in mixed 129/C57Bl6/CD1 genetic background,
and all experimental procedures were carried out in accordance with the
Administrative Panel on Laboratory Animal Care protocol and the institutional
guidelines by the Veterinary Service Center at Stanford University.MADM-7GT,
MADM-7TG, MADM-12GT, and MADM-12TG mice are available at Jackson
Laboratory Repository (http://jaxmice.jax.org) with the following JAX Stock
Numbers: 021457, MADM-7GT; 021458, MADM-7TG; 021460, MADM-12GT;
and 021461, MADM-12TG.
Analysis of Marker Expression in MADM Animals
Experimental MADM mice at various ages were perfused, and organs were
removed and processed for cryosections essentially as described (Hippen-
meyer et al., 2010). Typically, we isolated the whole brain, heart, and the
largest leaflets of the lung and liver from postnatal mice. Whole embryos
were isolated and left intact for processing except that the bodywas separated
from the head, and the limbs were removed. The brain, heart, and lung were
cryosectioned sagittally at 60 mm (brain) and 14 mm (heart and lung); coronal
sections were acquired from the liver at 14 mm. The fluorescent tdTomato
and GFP signals were usually not amplified by antibody staining, but tissue
sections were stained with DAPI (Invitrogen) to visualize nuclei and confocal
images acquired using a LSM 510 (Zeiss).
Generation and Analysis of MADM Clones in Liver
For the induction of G2-X MADM clones in liver, we set up timed pregnancies,
injected TM intraperitoneally at E12, and isolated embryos at E16. Embryos
were fixed in 4% PFA/PB overnight, cryoprotected in 30% sucrose/PBS,Cell Reports 3, 960–967, March 28, 2013 ª2013 The Authors 965
embedded in OCT, and sectioned in the sagittal plane at 30 mm. The frequency
of MADM clone generation was extremely low and varied between cohorts
with slightly different genetic background.
Computation of PP/MM Ratios
Pyramidal cells in hippocampal area CA1 were counted in confocal images
from 16 (MADM-7GT/TG;Hprt-Cre+/) and 11 (MADM-12GT/TG;Hprt-Cre+/)
cryosections (derived from three animals for each genotype) encompassing
the whole CA1 area. Purkinje cells in cerebella were counted in all consecutive
sections from four (MADM-7GT/TG;Hprt-Cre+/) and three (MADM-12GT/TG;
Hprt-Cre+/) entire half-brains derived from more than two animals each. For
quantification of heart cardiomyocyte and liver hepatocyte populations, the
green (GFP) and red (tdTomato) MADM signals were first extracted manually
from confocal images derived from cryosections to separate them from the
yellow GFP+/tdTomato+ signal. The total areas of green and red signals,
respectively, were then computed from binary images using a custom MAT-
LAB script. The geometric means ± SEM of the paternal/maternal ratios
were calculated in Excel, and significance was determined using Student’s t
test: *p < 0.05 and **p < 0.01.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2013.02.002.
LICENSING INFORMATION
This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium,
provided the original author and source are credited.
ACKNOWLEDGMENTS
We thank H. Zong for FLLFL MADM cassettes and discussions about MADM;
Y. Chen-Tsai and the Stanford Transgenic Facility for generating knockin mice;
A. Efstratiadis and C. Walsh for providing Igf2 mutant mice; C. Manalac, J.
Zhong, K. Jaeckle, C. Nguyen, and M. Shu for technical support; and H.
Chang, N. Makki, B. Weissbourd, and T. Mosca for helpful comments on the
manuscript. This work was supported by the European Molecular Biology
Organization ALTF 851-2005 (to S.H.), Human Frontier Science ProgramOrga-
nization LT00805/2006-L (to S.H.), Swiss National Science Foundation
PA00P3_124160 and PA00P3_136482 (to S.H.), and NIH grants R01-
NS050835 (to L.L.) and R01-HD060579 (R.L.J.). L.L. is an investigator of the
Howard Hughes Medical Institute.
Received: October 25, 2012
Revised: January 5, 2013
Accepted: February 1, 2013
Published: February 28, 2013
REFERENCES
Barlow, D.P. (2011). Genomic imprinting: a mammalian epigenetic discovery
model. Annu. Rev. Genet. 45, 379–403.
Bartolomei, M.S., and Ferguson-Smith, A.C. (2011). Mammalian genomic
imprinting. Cold Spring Harb. Perspect. Biol. 3, a002592.
Bartolomei, M.S., Zemel, S., and Tilghman, S.M. (1991). Parental imprinting of
the mouse H19 gene. Nature 351, 153–155.
Barton, S.C., Surani, M.A., and Norris, M.L. (1984). Role of paternal and
maternal genomes in mouse development. Nature 311, 374–376.
Caspary, T., Cleary, M.A., Perlman, E.J., Zhang, P., Elledge, S.J., and Tilgh-
man, S.M. (1999). Oppositely imprinted genes p57(Kip2) and igf2 interact in
a mouse model for Beckwith-Wiedemann syndrome. Genes Dev. 13, 3115–
3124.966 Cell Reports 3, 960–967, March 28, 2013 ª2013 The AuthorsCattanach, B.M., and Kirk, M. (1985). Differential activity of maternally and
paternally derived chromosome regions in mice. Nature 315, 496–498.
Chao, W., and D’Amore, P.A. (2008). IGF2: epigenetic regulation and role in
development and disease. Cytokine Growth Factor Rev. 19, 111–120.
Davies, K., Bowden, L., Smith, P., Dean, W., Hill, D., Furuumi, H., Sasaki, H.,
Cattanach, B., and Reik, W. (2002). Disruption of mesodermal enhancers for
Igf2 in the minute mutant. Development 129, 1657–1668.
DeChiara, T.M., Efstratiadis, A., and Robertson, E.J. (1990). A growth-defi-
ciency phenotype in heterozygous mice carrying an insulin-like growth factor
II gene disrupted by targeting. Nature 345, 78–80.
DeChiara, T.M., Robertson, E.J., and Efstratiadis, A. (1991). Parental
imprinting of the mouse insulin-like growth factor II gene. Cell 64, 849–859.
Espinosa, J.S., Wheeler, D.G., Tsien, R.W., and Luo, L. (2009). Uncoupling
dendrite growth and patterning: single-cell knockout analysis of NMDA
receptor 2B. Neuron 62, 205–217.
Feinberg, A.P. (2007). Phenotypic plasticity and the epigenetics of human
disease. Nature 447, 433–440.
Ferguson-Smith, A.C. (2011). Genomic imprinting: the emergence of an epige-
netic paradigm. Nat. Rev. Genet. 12, 565–575.
Ferguson-Smith, A.C., Cattanach, B.M., Barton, S.C., Beechey, C.V., and Sur-
ani, M.A. (1991). Embryological and molecular investigations of parental
imprinting on mouse chromosome 7. Nature 351, 667–670.
Ferro´n, S.R., Charalambous, M., Radford, E., McEwen, K., Wildner, H., Hind,
E., Morante-Redolat, J.M., Laborda, J., Guillemot, F., Bauer, S.R., et al.
(2011). Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes
regulates neurogenesis. Nature 475, 381–385.
Garfield, A.S., Cowley, M., Smith, F.M., Moorwood, K., Stewart-Cox, J.E., Gil-
roy, K., Baker, S., Xia, J., Dalley, J.W., Hurst, L.D., et al. (2011). Distinct phys-
iological and behavioural functions for parental alleles of imprinted Grb10.
Nature 469, 534–538.
Guo, C., Yang, W., and Lobe, C.G. (2002). A Cre recombinase transgene with
mosaic, widespread tamoxifen-inducible action. Genesis 32, 8–18.
Hatada, I., and Mukai, T. (1995). Genomic imprinting of p57KIP2, a cyclin-
dependent kinase inhibitor, in mouse. Nat. Genet. 11, 204–206.
Hippenmeyer, S., Youn, Y.H., Moon, H.M., Miyamichi, K., Zong, H., Wynshaw-
Boris, A., and Luo, L. (2010). Genetic mosaic dissection of Lis1 and Ndel1 in
neuronal migration. Neuron 68, 695–709.
Lehtinen, M.K., Zappaterra, M.W., Chen, X., Yang, Y.J., Hill, A.D., Lun, M.,
Maynard, T., Gonzalez, D., Kim, S., Ye, P., et al. (2011). The cerebrospinal fluid
provides a proliferative niche for neural progenitor cells. Neuron 69, 893–905.
Liu, C., Sage, J.C., Miller, M.R., Verhaak, R.G., Hippenmeyer, S., Vogel, H.,
Foreman, O., Bronson, R.T., Nishiyama, A., Luo, L., and Zong, H. (2011).
Mosaic analysis with double markers reveals tumor cell of origin in glioma.
Cell 146, 209–221.
Mabb, A.M., Judson, M.C., Zylka, M.J., and Philpot, B.D. (2011). Angelman
syndrome: insights into genomic imprinting and neurodevelopmental pheno-
types. Trends Neurosci. 34, 293–303.
Matsuoka, S., Edwards, M.C., Bai, C., Parker, S., Zhang, P., Baldini, A.,
Harper, J.W., and Elledge, S.J. (1995). p57KIP2, a structurally distinct member
of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Genes Dev. 9, 650–662.
McGrath, J., and Solter, D. (1984). Completion of mouse embryogenesis
requires both the maternal and paternal genomes. Cell 37, 179–183.
McLaughlin, K.J., Kochanowski, H., Solter, D., Schwarzkopf, G., Szabo´, P.E.,
and Mann, J.R. (1997). Roles of the imprinted gene Igf2 and paternal duplica-
tion of distal chromosome 7 in the perinatal abnormalities of androgenetic
mouse chimeras. Development 124, 4897–4904.
Muzumdar, M.D., Luo, L., and Zong, H. (2007). Modeling sporadic loss of
heterozygosity in mice by using mosaic analysis with double markers
(MADM). Proc. Natl. Acad. Sci. USA 104, 4495–4500.
Nicholls, R.D., and Knepper, J.L. (2001). Genome organization, function, and
imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics
Hum. Genet. 2, 153–175.
Stanger, B.Z. (2008). Organ size determination and the limits of regulation. Cell
Cycle 7, 318–324.
Stanger, B.Z., Tanaka, A.J., and Melton, D.A. (2007). Organ size is limited by
the number of embryonic progenitor cells in the pancreas but not the liver.
Nature 445, 886–891.
Surani, M.A., Barton, S.C., and Norris, M.L. (1984). Development of reconsti-
tuted mouse eggs suggests imprinting of the genome during gametogenesis.
Nature 308, 548–550.
Tang, S.H., Silva, F.J., Tsark, W.M., and Mann, J.R. (2002). A Cre/loxP-deleter
transgenic line in mouse strain 129S1/SvImJ. Genesis 32, 199–202.Tasic, B., Miyamichi, K., Hippenmeyer, S., Dani, V.S., Zeng, H., Joo, W., Zong,
H., Chen-Tsai, Y., and Luo, L. (2012). Extensions of MADM (mosaic analysis
with double markers) in mice. PLoS One 7, e33332.
Wilkinson, L.S., Davies, W., and Isles, A.R. (2007). Genomic imprinting effects
on brain development and function. Nat. Rev. Neurosci. 8, 832–843.
Williamson, C.M., B.A., Thomas, S., Beechey, C.V., Hancock, J., Cattanach,
B.M., and Peters, J. (2013). MRC Harwell, Oxfordshire. World Wide Web
Site-Mouse Imprinting Data and References. http://www.har.mrc.ac.uk/
research/genomic_imprinting/.
Zong, H., Espinosa, J.S., Su, H.H., Muzumdar, M.D., and Luo, L. (2005).
Mosaic analysis with double markers in mice. Cell 121, 479–492.Cell Reports 3, 960–967, March 28, 2013 ª2013 The Authors 967
